Approaches to relapse after allogeneic stem cell transplantation.

Standard

Approaches to relapse after allogeneic stem cell transplantation. / Kröger, Nicolaus.

in: CURR OPIN ONCOL, Jahrgang 23, Nr. 2, 2, 2011, S. 203-208.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{d76ff8df91b64ebabd1bc80bf31336d7,
title = "Approaches to relapse after allogeneic stem cell transplantation.",
abstract = "Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor for patients who relapsed to an allograft since effective treatment options are limited. Here, we review the available and upcoming treatment approaches for relapse.",
keywords = "Humans, Recurrence, Hematopoietic Stem Cell Transplantation/*methods, Hematologic Neoplasms/*surgery, Humans, Recurrence, Hematopoietic Stem Cell Transplantation/*methods, Hematologic Neoplasms/*surgery",
author = "Nicolaus Kr{\"o}ger",
year = "2011",
language = "English",
volume = "23",
pages = "203--208",
number = "2",

}

RIS

TY - JOUR

T1 - Approaches to relapse after allogeneic stem cell transplantation.

AU - Kröger, Nicolaus

PY - 2011

Y1 - 2011

N2 - Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor for patients who relapsed to an allograft since effective treatment options are limited. Here, we review the available and upcoming treatment approaches for relapse.

AB - Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor for patients who relapsed to an allograft since effective treatment options are limited. Here, we review the available and upcoming treatment approaches for relapse.

KW - Humans

KW - Recurrence

KW - Hematopoietic Stem Cell Transplantation/methods

KW - Hematologic Neoplasms/surgery

KW - Humans

KW - Recurrence

KW - Hematopoietic Stem Cell Transplantation/methods

KW - Hematologic Neoplasms/surgery

M3 - SCORING: Journal article

VL - 23

SP - 203

EP - 208

IS - 2

M1 - 2

ER -